Premium
Extracellular Hmgb1 Functions as an Innate Immune‐Mediator Implicated in Murine Cardiac Allograft Acute Rejection
Author(s) -
Huang Y.,
Yin H.,
Han J.,
Huang B.,
Xu J.,
Zheng F.,
Tan Z.,
Fang M.,
Rui L.,
Chen D.,
Wang S.,
Zheng X.,
Wang C.Y.,
Gong F.
Publication year - 2007
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2007.01734.x
Subject(s) - hmgb1 , immune system , innate immune system , medicine , transplantation , immunology , inflammation , mediator , acquired immune system , transplant rejection , extracellular , biology , microbiology and biotechnology
Hmgb1, an evolutionarily conserved chromosomal protein, was recently re‐discovered to be an innate immune‐mediator contributing to both innate and adaptive immune responses. Here, we show a pivotal role for Hmgb1 in acute allograft rejection in a murine cardiac transplantation model. Extracellular Hmgb1 was found to be a potent stimulator for adaptive immune responses. Hmgb1 can be either passively released from damaged cells after organ harvest and ischemia/reperfusion insults, or actively secreted by allograft infiltrated immune cells. After transplantation, allografts show a significant temporal up‐regulation of Hmgb1 expression accompanied by inflammatory infiltration, a consequence of graft destruction. These data suggest the involvement of Hmgb1 in acute allograft rejection. In line with these observations, treatment of recipients with rA‐box, a specific blockade for endogenous Hmgb1, significantly prolonged cardiac allograft survival as compared to those recipients treated with either rGST or control vehicle. The enhanced graft survival is associated with reduced allograft expression of TNFα, IFNγ and Hmgb1 and impaired Th1 immune response.